Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

1.

Expression of JMJD2A in infiltrating duct carcinoma was markedly higher than fibroadenoma, and associated with expression of ARHI, p53 and ER in infiltrating duct carcinoma.

Li BX, Li J, Luo CL, Zhang MC, Li H, Li LL, Xu HF, Shen YW, Xue AM, Zhao ZQ.

Indian J Exp Biol. 2013 Mar;51(3):208-17.

PMID:
23678541
[PubMed - indexed for MEDLINE]
2.

Alterations of ER, PR, HER-2/neu, and P53 protein expression in ductal breast carcinomas and clinical implications.

Liu C, Zhang H, Shuang C, Lu Y, Jin F, Xu H, Lu P.

Med Oncol. 2010 Sep;27(3):747-52. doi: 10.1007/s12032-009-9279-8. Epub 2009 Aug 6.

PMID:
19657752
[PubMed - indexed for MEDLINE]
3.

JMJD2A contributes to breast cancer progression through transcriptional repression of the tumor suppressor ARHI.

Li LL, Xue AM, Li BX, Shen YW, Li YH, Luo CL, Zhang MC, Jiang JQ, Xu ZD, Xie JH, Zhao ZQ.

Breast Cancer Res. 2014 May 30;16(3):R56. doi: 10.1186/bcr3667.

PMID:
24886710
[PubMed - in process]
Free PMC Article
4.

[Effect of neoadjuvant chemotherapy on estrogen and progesterone receptors and P53 and CerbB-2 in breast cancer].

Bao G, Yang DQ, Zhou B, Liu P, Wang S, Cheng L.

Zhonghua Yi Xue Za Zhi. 2007 Oct 30;87(40):2843-5. Chinese.

PMID:
18167290
[PubMed - indexed for MEDLINE]
5.

The prognostic value of p53 and c-erbB-2 expression, proliferative activity and angiogenesis in node-negative breast carcinoma.

Erdem O, Dursun A, Coşkun U, Günel N.

Tumori. 2005 Jan-Feb;91(1):46-52.

PMID:
15850004
[PubMed - indexed for MEDLINE]
6.
7.
8.

Expression and mutational analysis of GATA3 in Malaysian breast carcinomas.

Bong PN, Zakaria Z, Muhammad R, Abdullah N, Ibrahim N, Emran NA, Syed Hussain SN.

Malays J Pathol. 2010 Dec;32(2):117-22.

PMID:
21329183
[PubMed - indexed for MEDLINE]
Free Article
9.
10.
11.

Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer.

Wang L, Hoque A, Luo RZ, Yuan J, Lu Z, Nishimoto A, Liu J, Sahin AA, Lippman SM, Bast RC Jr, Yu Y.

Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3660-6.

PMID:
14506155
[PubMed - indexed for MEDLINE]
Free Article
12.

c-erbB-2, p53 protein expression and steroid hormone receptors in breast carcinomas: an immunohistochemical study.

Yokota T, Imamura M, Teshima S, Suzuki H, Tezuka F, Kikuchi S, Kunii Y, Yamauchi H.

Anticancer Res. 1999 Sep-Oct;19(5B):4007-12.

PMID:
10628345
[PubMed - indexed for MEDLINE]
13.

[Expression of ER, PR and cyclin D1 in breast infiltrating ductal carcinoma and their clinicopathological significance].

Wang ZB, Zhao P, Liu M, Li XH.

Zhonghua Yi Xue Za Zhi. 2005 Mar 2;85(8):514-7. Chinese.

PMID:
15949328
[PubMed - indexed for MEDLINE]
14.

P53 expression in patients with malignant and benign breast diseases.

Kalogeraki A, Panayiotides J, Tamiolakis D, Tzardi M, Chaniotis V, Chalkiadakis G, Melissas J, Stiftsis D, Kanavaros P, Delides GS.

Anticancer Res. 2000 May-Jun;20(3A):1801-5.

PMID:
10928110
[PubMed - indexed for MEDLINE]
15.

p53 in node-negative breast carcinoma: an immunohistochemical study of epidemiologic risk factors, histologic features, and prognosis.

Rosen PP, Lesser ML, Arroyo CD, Cranor M, Borgen P, Norton L.

J Clin Oncol. 1995 Apr;13(4):821-30.

PMID:
7707107
[PubMed - indexed for MEDLINE]
Free Article
16.

p53 gene alteration and protein expression in Iranian women with infiltrative ductal breast carcinoma.

Pezeshki AM, Farjadian S, Talei A, Vasei M, Gharesi-Fard B, Doroudchi M, Ghaderi A.

Cancer Lett. 2001 Aug 10;169(1):69-75.

PMID:
11410327
[PubMed - indexed for MEDLINE]
17.

Loss of bcl-2 expression in ductal carcinoma in situ of the breast relates to poor histological differentiation and to expression of p53 and c-erbB-2 proteins.

Quinn CM, Ostrowski JL, Harkins L, Rice AJ, Loney DP.

Histopathology. 1998 Dec;33(6):531-6.

PMID:
9870147
[PubMed - indexed for MEDLINE]
18.

[Expression and clinical significance of LRP16 gene in human breast cancer].

Liao DX, Han WD, Zhao YL, Pu YD, Mu YM, Luo CH, Li XH.

Ai Zheng. 2006 Jul;25(7):866-70. Chinese.

PMID:
16831279
[PubMed - indexed for MEDLINE]
19.

p53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer.

Barbareschi M, Leonardi E, Mauri FA, Serio G, Dalla Palma P.

Am J Clin Pathol. 1992 Oct;98(4):408-18.

PMID:
1357956
[PubMed - indexed for MEDLINE]
20.

[ErbB-2 expression and hormone receptor status in areas of transition from in situ to invasive ductal breast carcinoma].

Peres RM, Derchain SF, Heinrich JK, Serra KP, Pinto GA, Soares FA, Sarian LO.

Rev Bras Ginecol Obstet. 2009 Sep;31(9):461-7. Portuguese.

PMID:
19876578
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk